Female sex, antidepressant use, and type of health insurance significantly influence semaglutide initiation. (HealthDay News) — Sociodemographic, health care, and clinical factors are associated with ...
Significant associations for semaglutide initiation included being female, using certain medication classes including antidepressants, and being covered by a point-of-service plan. (HealthDay News ...
Alexandra Sowa's new book The Ozempic Revolution is intended to be the "first comprehensive user guide" to GLP-1 drugs like ...
Topline data were announced from a phase 3b trial evaluating investigational semaglutide 7.2mg in adults with obesity.
Early research suggests GLP-1 drugs could prevent or treat Alzheimer's Disease. Results from a big clinical trial could soon ...
Scientists find Ozempic may treat cancer, Alzheimer's and more. Is it hype or truly a "wonder drug?"
Like why, for example, having diabetes can put you at higher risk of Alzheimer’s. Or the mysterious relationship between osteoarthritis and obesity. Semaglutide mimics the action of the natural ...
INSIDER on MSN6d
A woman regained weight after she stopped taking semaglutide. Now she works 2 jobs to afford it.A woman who lost 64 pounds on a compounded form of the weight loss drug semaglutide, marketed as Wegovy and Ozempic, started ...
The U.S. Food and Drug Administration (FDA) has approved Novo Nordisks (NYSE:NVO) Ozempic for reducing the risk of kidney ...
The author of a new guidebook on GLP-1s and other experts share their tips for how clinicians can optimize patient success ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback